Outset Medical (OM) Stock Forecast, Price Target & Predictions
OM Stock Forecast
Outset Medical stock forecast is as follows: an average price target of $11.00 (represents a 1673.05% upside from OM’s last price of $0.62) and a rating consensus of 'Buy', based on 9 wall street analysts offering a 1-year stock forecast.
OM Price Target
OM Analyst Ratings
Outset Medical Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Aug 08, 2024 | Shagun Singh | RBC Capital | $3.00 | $3.40 | -11.76% | 383.56% |
Jun 21, 2024 | Shagun Singh | RBC Capital | $6.00 | $3.58 | 67.36% | 867.12% |
Apr 17, 2024 | Rick Wise | Stifel Nicolaus | $6.00 | $2.27 | 164.32% | 867.12% |
Apr 08, 2024 | Maria Thibault | BTIG | $6.00 | $2.05 | 192.68% | 867.12% |
Apr 05, 2024 | Kristen Stewart | C.L. King | $6.00 | $1.94 | 209.28% | 867.12% |
Nov 11, 2022 | - | RBC Capital | $23.00 | $17.51 | 31.35% | 3607.29% |
Aug 03, 2022 | - | Goldman Sachs | $34.00 | $19.45 | 74.76% | 5380.34% |
Jul 18, 2022 | - | Stifel Nicolaus | $24.00 | $16.91 | 41.89% | 3768.47% |
Jun 14, 2022 | - | Stifel Nicolaus | $30.00 | $20.41 | 46.99% | 4735.59% |
Outset Medical Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 1 | 5 |
Avg Price Target | - | $3.00 | $5.40 |
Last Closing Price | $0.62 | $0.62 | $0.62 |
Upside/Downside | -100.00% | 383.56% | 770.41% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Aug 08, 2024 | Cowen & Co. | Buy | Buy | Hold |
Aug 08, 2024 | RBC Capital | Outperform | Sector Perform | Downgrade |
Jun 21, 2024 | RBC Capital | Sector Perform | Outperform | Upgrade |
Apr 08, 2024 | BTIG | - | Buy | Initialise |
Aug 17, 2023 | UBS | - | Neutral | Initialise |
Aug 17, 2023 | RBC Capital | Outperform | Sector Perform | Initialise |
Aug 17, 2023 | BMO Capital | - | Outperform | Initialise |
Aug 17, 2023 | Jefferies | - | Buy | Initialise |
Aug 17, 2023 | Morgan Stanley | - | Equal-Weight | Initialise |
Aug 17, 2023 | Piper Sandler | - | Overweight | Initialise |
Outset Medical Financial Forecast
Outset Medical Revenue Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $30.36M | $36.04M | $33.47M | $32.01M | $27.76M | $25.06M | $30.55M | $28.15M | $26.32M | $25.22M | $22.92M | $17.25M | $13.76M |
Avg Forecast | $46.50M | $42.73M | $40.86M | $37.96M | $33.87M | $32.26M | $30.56M | $29.28M | $27.77M | $26.84M | $31.17M | $30.35M | $30.50M | $30.39M | $34.79M | $31.75M | $30.92M | $25.22M | $27.50M | $30.11M | $26.43M | $25.13M | $23.73M | $21.45M | $13.76M | $11.53M |
High Forecast | $46.50M | $42.73M | $40.86M | $37.96M | $33.87M | $32.26M | $30.56M | $29.28M | $27.77M | $26.98M | $31.17M | $30.35M | $30.62M | $30.40M | $34.79M | $31.75M | $30.92M | $25.22M | $27.50M | $30.11M | $26.43M | $25.13M | $23.73M | $21.45M | $13.76M | $11.53M |
Low Forecast | $46.50M | $42.73M | $40.86M | $37.96M | $33.87M | $32.26M | $30.56M | $29.28M | $27.77M | $26.57M | $31.17M | $30.35M | $30.40M | $30.35M | $34.79M | $31.75M | $30.92M | $25.22M | $27.50M | $30.11M | $26.43M | $25.13M | $23.73M | $21.45M | $13.76M | $11.53M |
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.04% | 1.05% | 1.04% | 1.10% | 0.91% | 1.01% | 1.07% | 1.05% | 1.06% | 1.07% | 1.25% | 1.19% |
Outset Medical EBITDA Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $-45.45M | $-43.48M | $-40.84M | $-37.92M | $-40.19M | $-43.26M | $-35.09M | $-40.68M | $-28.73M | $-28.43M | $-28.32M | $-29.68M | $-41.43M |
Avg Forecast | $-46.50M | $-42.73M | $-40.86M | $-37.96M | $-33.87M | $-32.26M | $-30.56M | $-29.28M | $-27.77M | $-26.84M | $-31.17M | $-38.92M | $-30.50M | $-30.39M | $-34.79M | $-35.39M | $-42.59M | $-25.22M | $-27.50M | $-32.17M | $-26.43M | $-25.13M | $-23.73M | $-31.86M | $-13.76M | $-38.62M |
High Forecast | $-46.50M | $-42.73M | $-40.86M | $-37.96M | $-33.87M | $-32.26M | $-30.56M | $-29.28M | $-27.77M | $-26.57M | $-31.17M | $-31.14M | $-30.40M | $-30.35M | $-34.79M | $-28.31M | $-34.07M | $-25.22M | $-27.50M | $-25.73M | $-26.43M | $-25.13M | $-23.73M | $-25.49M | $-13.76M | $-30.90M |
Low Forecast | $-46.50M | $-42.73M | $-40.86M | $-37.96M | $-33.87M | $-32.26M | $-30.56M | $-29.28M | $-27.77M | $-26.98M | $-31.17M | $-46.71M | $-30.62M | $-30.40M | $-34.79M | $-42.46M | $-51.10M | $-25.22M | $-27.50M | $-38.60M | $-26.43M | $-25.13M | $-23.73M | $-38.23M | $-13.76M | $-46.35M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.50% | 1.25% | 1.15% | 0.89% | 1.59% | 1.57% | 1.09% | 1.54% | 1.14% | 1.20% | 0.89% | 2.16% | 1.07% |
Outset Medical Net Income Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $-46.18M | $-44.05M | $-43.97M | $-41.44M | $-40.78M | $-43.84M | $-36.89M | $-41.23M | $-30.47M | $-30.21M | $-30.02M | $-32.04M | $-42.29M |
Avg Forecast | $-14.65M | $-15.93M | $-17.19M | $-18.34M | $-17.29M | $-18.24M | $-18.83M | $-19.27M | $-20.75M | $-22.83M | $-23.15M | $-40.92M | $-33.20M | $-36.46M | $-39.17M | $-37.20M | $-43.17M | $-38.70M | $-33.00M | $-33.82M | $-36.83M | $-36.98M | $-35.62M | $-33.78M | $-34.45M | $-39.43M |
High Forecast | $-14.65M | $-15.93M | $-17.19M | $-18.34M | $-17.29M | $-18.24M | $-18.83M | $-19.27M | $-20.75M | $-20.11M | $-23.15M | $-32.74M | $-29.94M | $-31.02M | $-39.17M | $-29.76M | $-34.54M | $-38.70M | $-33.00M | $-27.05M | $-36.83M | $-36.98M | $-35.62M | $-27.02M | $-34.45M | $-31.54M |
Low Forecast | $-14.65M | $-15.93M | $-17.19M | $-18.34M | $-17.29M | $-18.24M | $-18.83M | $-19.27M | $-20.75M | $-25.00M | $-23.15M | $-49.10M | $-35.92M | $-39.19M | $-39.17M | $-44.64M | $-51.80M | $-38.70M | $-33.00M | $-40.58M | $-36.83M | $-36.98M | $-35.62M | $-40.53M | $-34.45M | $-47.31M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.27% | 1.12% | 1.18% | 0.96% | 1.05% | 1.33% | 1.09% | 1.12% | 0.82% | 0.85% | 0.89% | 0.93% | 1.07% |
Outset Medical SG&A Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $36.53M | $36.27M | $36.12M | $33.65M | $32.28M | $33.98M | $30.09M | $32.71M | $23.36M | $22.93M | $22.39M | $24.25M | $26.43M |
Avg Forecast | $61.83M | $56.81M | $54.33M | $50.47M | $45.04M | $42.90M | $40.64M | $38.93M | $36.92M | $35.69M | $41.45M | $40.36M | $40.56M | $40.41M | $46.27M | $30.34M | $41.11M | $33.54M | $36.56M | $27.58M | $35.14M | $33.41M | $31.55M | $28.52M | $18.30M | $15.34M |
High Forecast | $61.83M | $56.81M | $54.33M | $50.47M | $45.04M | $42.90M | $40.64M | $38.93M | $36.92M | $35.87M | $41.45M | $40.36M | $40.72M | $40.43M | $46.27M | $36.40M | $41.11M | $33.54M | $36.56M | $33.09M | $35.14M | $33.41M | $31.55M | $28.52M | $18.30M | $15.34M |
Low Forecast | $61.83M | $56.81M | $54.33M | $50.47M | $45.04M | $42.90M | $40.64M | $38.93M | $36.92M | $35.33M | $41.45M | $40.36M | $40.42M | $40.36M | $46.27M | $24.27M | $41.11M | $33.54M | $36.56M | $22.06M | $35.14M | $33.41M | $31.55M | $28.52M | $18.30M | $15.34M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.90% | 0.78% | 1.19% | 0.82% | 0.96% | 0.93% | 1.09% | 0.93% | 0.70% | 0.73% | 0.79% | 1.33% | 1.72% |
Outset Medical EPS Forecast
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 4 | 5 | 4 | 1 | 3 | 6 | 3 | 3 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.93 | $-0.90 | $-0.90 | $-0.86 | $-0.85 | $-0.92 | $-0.78 | $-0.87 | $-0.65 | $-0.66 | $-0.70 | $-0.75 | $-3.44 |
Avg Forecast | $-0.28 | $-0.31 | $-0.33 | $-0.35 | $-0.33 | $-0.35 | $-0.36 | $-0.37 | $-0.40 | $-0.44 | $-0.45 | $-0.55 | $-0.64 | $-0.70 | $-0.76 | $-0.73 | $-0.79 | $-0.75 | $-0.64 | $-0.68 | $-0.71 | $-0.71 | $-0.69 | $-0.80 | $-0.66 | $-2.27 |
High Forecast | $-0.28 | $-0.31 | $-0.33 | $-0.35 | $-0.33 | $-0.35 | $-0.36 | $-0.37 | $-0.40 | $-0.39 | $-0.45 | $-0.55 | $-0.58 | $-0.60 | $-0.76 | $-0.73 | $-0.79 | $-0.75 | $-0.64 | $-0.68 | $-0.71 | $-0.71 | $-0.69 | $-0.80 | $-0.66 | $-2.27 |
Low Forecast | $-0.28 | $-0.31 | $-0.33 | $-0.35 | $-0.33 | $-0.35 | $-0.36 | $-0.37 | $-0.40 | $-0.48 | $-0.45 | $-0.55 | $-0.69 | $-0.76 | $-0.76 | $-0.73 | $-0.79 | $-0.75 | $-0.64 | $-0.68 | $-0.71 | $-0.71 | $-0.69 | $-0.80 | $-0.66 | $-2.27 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.32% | 1.19% | 1.23% | 1.09% | 1.14% | 1.45% | 1.14% | 1.23% | 0.91% | 0.96% | 0.87% | 1.13% | 1.51% |
Outset Medical Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
OM | Outset Medical | $0.62 | $11.00 | 1674.19% | Buy |
NVRO | Nevro | $5.35 | $32.72 | 511.59% | Hold |
SGHT | Sight Sciences | $4.66 | $10.25 | 119.96% | Hold |
NPCE | NeuroPace | $6.37 | $12.88 | 102.20% | Buy |
OFIX | Orthofix Medical | $17.33 | $31.00 | 78.88% | - |
LUNG | Pulmonx | $7.12 | $11.93 | 67.56% | Buy |
SIBN | SI-BONE | $13.63 | $20.00 | 46.74% | Buy |
KIDS | OrthoPediatrics | $28.74 | $39.60 | 37.79% | Buy |
CNMD | CONMED | $70.47 | $96.00 | 36.23% | Buy |
NARI | Inari Medical | $48.93 | $66.11 | 35.11% | Buy |
INSP | Inspire Medical Systems | $192.71 | $238.00 | 23.50% | Buy |
CVRX | CVRx | $15.05 | $16.33 | 8.50% | Buy |
CLPT | ClearPoint Neuro | $12.74 | $12.00 | -5.81% | Buy |
SWAV | ShockWave Medical | $334.75 | $258.17 | -22.88% | Hold |
OM Forecast FAQ
Is Outset Medical a good buy?
Yes, according to 9 Wall Street analysts, Outset Medical (OM) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 6 'Buy' recommendations, accounting for 66.67% of OM's total ratings.
What is OM's price target?
Outset Medical (OM) average price target is $11 with a range of $3 to $34, implying a 1673.05% from its last price of $0.62. The data is based on 9 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Outset Medical stock go up soon?
According to Wall Street analysts' prediction for OM stock, the company can go up by 1673.05% (from the last price of $0.62 to the average price target of $11), up by 5380.34% based on the highest stock price target, and up by 383.56% based on the lowest stock price target.
Can Outset Medical stock reach $1?
OM's average twelve months analyst stock price target of $11 supports the claim that Outset Medical can reach $1 in the near future.
What are Outset Medical's analysts' financial forecasts?
Outset Medical's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $125.97M (high $125.97M, low $125.97M), average EBITDA is $-126M (high $-126M, low $-126M), average net income is $-73.633M (high $-73.633M, low $-73.633M), average SG&A $167.51M (high $167.51M, low $167.51M), and average EPS is $-1.419 (high $-1.419, low $-1.419). OM's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $168.04M (high $168.04M, low $168.04M), average EBITDA is $-168M (high $-168M, low $-168M), average net income is $-66.111M (high $-66.111M, low $-66.111M), average SG&A $223.44M (high $223.44M, low $223.44M), and average EPS is $-1.274 (high $-1.274, low $-1.274).
Did the OM's actual financial results beat the analysts' financial forecasts?
Based on Outset Medical's last annual report (Dec 2022), the company's revenue was $115.38M, beating the average analysts forecast of $113.74M by 1.43%. Apple's EBITDA was $-158M, beating the average prediction of $-127M by 23.73%. The company's net income was $-163M, beating the average estimation of $-149M by 9.60%. Apple's SG&A was $130M, missing the average forecast of $138.79M by -6.34%. Lastly, the company's EPS was $-3.38, beating the average prediction of $-2.852 by 18.51%. In terms of the last quarterly report (Sep 2023), Outset Medical's revenue was $30.36M, missing the average analysts' forecast of $30.39M by -0.10%. The company's EBITDA was $-45.454M, beating the average prediction of $-30.391M by 49.56%. Outset Medical's net income was $-46.18M, beating the average estimation of $-36.464M by 26.64%. The company's SG&A was $36.54M, missing the average forecast of $40.41M by -9.59%. Lastly, the company's EPS was $-0.93, beating the average prediction of $-0.703 by 32.32%